Muse Treatment has published a new educational resource examining how addiction and co-occurring mental health conditions can be treated within a coordinated clinical plan. The resource, “How Does Dual Diagnosis Treatment Work?” explains how substance use disorders can occur alongside depression, anxiety, post-traumatic stress disorder, bipolar disorder, and other psychiatric conditions, and why assessment of both conditions can influence treatment decisions.
The publication comes as newly available Los Angeles County treatment data underscores the overlap between substance use and mental health needs. The Los Angeles County Department of Public Health’s FY2024-2025 annual treatment report found that 58 percent of patients entering publicly funded substance use disorder treatment reported mental health issues. The report also showed that patients received care across residential, outpatient, intensive outpatient, withdrawal-management and opioid-treatment programs, illustrating the range of clinical needs present within the county treatment system.
The resource is also timely amid changing overdose trends. In June 2026, the Los Angeles County Department of Public Health reported that drug-related overdose and poisoning deaths decreased for a third consecutive year. Deaths declined another 6 percent from 2024 to 2025, including a 10 percent reduction in fentanyl-related deaths. County officials attributed the trend to prevention, harm-reduction, treatment and recovery initiatives, while continuing to emphasize the need for access to substance use services.
Against that public-health backdrop, Muse Treatment’s article focuses on integrated care for patients whose substance use occurs alongside psychiatric symptoms. The resource describes dual diagnosis, also referred to clinically as co-occurring disorders, as the presence of a substance use disorder together with a mental health condition. It explains that coordinated treatment can include psychiatric evaluation, medical stabilization when required, behavioral therapy, medication management, and continued addiction treatment within a unified plan.
National data reinforces the relevance of that approach. SAMHSA’s 2024 National Survey on Drug Use and Health estimated that 6.9 million U.S. adults experienced both a serious mental illness and a substance use disorder during the year. Nearly half of the 14.6 million adults with serious mental illness also had a substance use disorder, demonstrating why psychiatric assessment can be important when patients enter addiction treatment.
Los Angeles County has likewise made integrated behavioral health care an explicit priority. The Department of Public Health states that its substance use treatment system supports coordination among substance use, mental health, physical health and related services, particularly for patients with co-occurring conditions. The county also provides training for treatment professionals focused specifically on recognizing, engaging, screening and assessing patients experiencing both mental health and substance use concerns.
Muse Treatment’s published Los Angeles information describes a continuum that includes medically supervised detoxification, inpatient residential treatment, outpatient programming and sober living. The provider also identifies cognitive behavioral therapy, dialectical behavior therapy, trauma-informed treatment, neurofeedback, medication management, medication-assisted treatment, and family therapy as approaches that may be incorporated based on a patient’s assessment and clinical needs.
Independent certification information provides an additional reference point for patients evaluating the organization. CARF International currently lists A New Start Treatment and Recovery, LLC, doing business as Muse Treatment, with adult certification at ASAM Level of Care 3.7 at its Culver City treatment locations. CARF’s independent listing verifies the organization and its certified level of substance use disorder care without relying on provider marketing claims.
For people entering a drug rehab near me search in Los Angeles, the new dual diagnosis resource provides a framework for looking beyond geographic distance. The presence of psychiatric services, appropriate treatment intensity, medical support, evidence-based behavioral therapies, and continuity between levels of care can help determine whether a program aligns with a patient’s assessed needs.
People comparing the best drug rehab centers may similarly benefit from reviewing verifiable clinical criteria rather than generalized rankings. Licensing, independent certification, available levels of treatment, psychiatric capabilities and treatment for co-occurring disorders provide more meaningful comparison points than promotional descriptions alone.
A patient considering inpatient drug rehab may require a structured residential environment because of substance use severity, withdrawal risks, psychiatric instability or other clinical factors. Muse Treatment’s published information describes inpatient residential treatment, along with medical detoxification and integrated mental health services, as part of its broader continuum.
For medically stable patients, outpatient drug rehab allows treatment to continue without overnight residence. Muse also operates outpatient services at 1251 Westwood Boulevard, while its published Los Angeles program information identifies an intensive outpatient drug rehab (IOP) option for patients who require more structure than conventional outpatient counseling but do not require continuous residential supervision.
The resource is relevant throughout the broader Los Angeles treatment market. Patients and families in West LA, Downtown LA, East LA, Westwood, and Westwood Village may encounter different treatment settings when comparing programs across LA. Geographic accessibility can affect transportation, family participation, and continued outpatient attendance, but the article emphasizes that the clinical relationship between addiction and mental health should also be considered when determining appropriate care.
The Los Angeles County treatment data makes that distinction particularly significant. With 58 percent of patients in the publicly funded treatment system reporting mental health issues during FY2024-2025, co-occurring concerns represent a substantial part of the local treatment population rather than an uncommon exception. The county report also documents use of residential, outpatient, intensive outpatient, and withdrawal-management services, reinforcing the importance of matching patients with an appropriate level of care.
Muse Treatment’s new resource ultimately places dual diagnosis within a broader movement toward coordinated behavioral health care. It explains why addiction symptoms and psychiatric conditions may need to be assessed together and why treatment can involve more than addressing substance use alone.
By publishing the resource, Muse Treatment is adding timely educational material to a 2026 discussion shaped by new Los Angeles County treatment data, evolving overdose trends and continued attention to integrated mental health and substance use services. For patients and families evaluating care, the article provides a practical framework for understanding how psychiatric assessment, addiction treatment and appropriate levels of clinical support can function as connected parts of a treatment plan.
###
For more information about Muse Treatment, contact the company here:
Muse Treatment
David Rofofsky
(800) 426-1818
info@musetreatment.com
1251 Westwood Blvd, Los Angeles, CA 90024
